News by subject: HEALTH

Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters, announced this week it has received FDA 510(k) clearance for reprocessing the Philips IVUS Eagle Eye Platinum RX Digital catheter. CEO and Founder,...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into a supply agreement...

Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces that it will be presenting results of its collaboration with the Microbiology Laboratory of the Queen Elizabeth Hospital of Health PEI ("Health PEI"), in...

Biogen Inc.  and Sage Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for zuranolone in the...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into a research...

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a leader in specialty ketamine pharmaceuticals, today announced that the U.S. Food and Drug Administration ("FDA") has granted...

Theralase® Technologies Inc. ("Theralase®" or the "Company") , a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds ("PDCs") and their associated drug formulations, used to safely...

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a leader in advancing specialty ketamine pharmaceuticals, today submitted its meeting package with the U.S. Food and Drug Administration ("FDA") to discuss advancing KETARXtm (racemic...

AVRICORE HEALTH INC. (the "Company" or "AVCR") is entering the second year of a multi-year growth plan to bring HealthTab, its turnkey solution for point of care testing and data management, to more pharmacies across Canada and the world. As part of...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce it submitted an Orphan Drug Designation ("ODD")...

California Prunes are well-known for their digestive health benefits, but did you know that enjoying about five prunes per day can also help support the health of your heart and bones? Filled with fibre, vitamins and antioxidants, California prunes...

TransCode Therapeutics, Inc. , an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today reported successful preclinical proof-of-mechanism studies with its immunotherapy candidate, TTX-RIGA, in melanoma....

For a fourth year, Black Rock Coffee Bar, a national boutique coffee chain, is partnering with JoyRx, the mission delivery of Children's Cancer Association, to help bring joy to kids and teens around the United States who are facing pediatric cancer...

Diagnos Inc. ("DIAGNOS", the "Corporation" or "we") a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce that the Quebec government has given the...

DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") , an artificial intelligence-driven digital health company focusing on improving brain health, today provided an update on its development and commercialization plans and expected milestones in...

Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in real-world applications for AI Eye Screeningtm and AI Predictive Biomarkerstm, has been approved to market its EyeArt® AI eye screening system in the European...

~ PEDMARK® is the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic Solid Tumors ~ ~ Orphan Drug Exclusivity Provides Seven Years of Market...

A survey conducted collaboratively by the COPD Foundation, a...

Aptose Biosciences Inc. ("Aptose") today announced the 120 mg monotherapy dosing of patients in the APTIVATE Phase 1/2 clinical trial of tuspetinib (formerly HM43239), an oral, mutation...

Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces that it is launching a new quality assessment product ("QAPtm") to support molecular diagnostic ("MDx") testing for the Non-Variola Orthopoxvirus ("Mpox"),...

Empire Communities, one of North America's largest privately held homebuilders, is pleased to announce the acquisition of ERTH ? a new green building initiative centered around the builder's commitment to offering more sustainable and healthier home...

January 30, 2023 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today presents its plan to create value with sustainable impact based on focused organic growth and scalable innovation, with...

January 30, 2023 Fourth-quarter highlights Group sales amounted to EUR 5.4 billion, with 3% comparable sales growth driven by component supply improvements, while Philips' supply chain conditions remain challengingComparable order...

Reliq Health Technologies Inc. ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the European Medicines Agency (EMA) has accepted a marketing authorization application (MAA) for lecanemab (Brand Name in the U.S.: LEQEMBItm), an...

Fennec...

Theralase® Technologies Inc. ("Theralase®" or the "Company") , a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds ("PDCs") and their associated drug formulations, used to safely...

Small Pharma Inc. (the "Company" or "Small Pharma"), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today announces that it will release top-line data from its Phase IIa trial of...

CentralReach, the leading provider of Autism and IDD Care software, today announced that Jackson Family Human Services, a behavioral health center that works to help individuals with autism and intellectual and developmental disabilities (IDDs)...

Pizza Nova announces its donation of $15,000 to SickKids Foundation. As part of its two-year partnership with the foundation, Pizza Nova created a limited edition vespa ornament, proceeds of which are going to the SickKids Foundation. A cheque...

Medela, the brand trusted by millions of moms1, announced today the launch of its first in-bra, wearable breast pump solution, the new Freestyle Hands-free Breast Pump. The new pump features ultra-lightweight, comfortable and discreet collection cups...

PharmAla Biotech Holdings Inc. ("PharmAla") , a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules (including MDMA) and its manufacturing partners have received an export permit for 300 grams of its...

Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), proudly celebrates a first-in-human Phase I clinical study for Skye Bioscience, Inc.'s (SKYE: OTCQB) proprietary, synthetic cannabinoid derivative,...

Mindset Pharma Inc. ("Mindset" or the "Company"), a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical needs,...

Evaxion Biotech A/S ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, today announced that the U.S. Food and Drug Administration ("FDA") has granted fast track...

The Canadian Men's Health Foundation (CMHF) announced today new and expanded mental health resources for their MindFit Toolkit presented by TELUS Health MyCaretm. More online screening tools, resources and counselling will now be available to...

XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce positive topline results from the XRX-OXY-101 ?...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that a...

Yesterday, the Ford government announced plans to expand private, for-profit health care in Ontario. The Ontario Federation of Labour (OFL) is calling the move, "entirely out of touch with what Ontarians want and need." According to polling...

According to the new Canada's Guidance on Alcohol and Health, 3?6 standard drinks a week represents a moderate risk to your health. After that, the more you drink, the more you increase your risk of seven types of cancer, most types of cardiovascular...

Diabetes Canada is proud to announce the winners of our End Diabetes Awards research competition. Each of the winning research projects has the potential to unlock new insights and breakthroughs in the field of diabetes management, care, and...

Medunik Canada Inc. ("Medunik"), a company dedicated to improving the health and quality of life of Canadians with rare diseases by bringing orphan drugs to Canada, is pleased to announce that on January 9, 2023, the Federal Court of Appeal of Canada...

The Ford government's plans to privatize our public hospitals' vital services are a fatal threat to the core tenet of Canadian Public Medicare that extra user fees are forbidden and patients will not be faced with user charges in their time of need....

VitalHub Corp. (the "Company" or "VitalHub") is pleased to announce a licensing agreement of VitalHub subsidiary Intouch with Health's ("Intouch") Patient Journey Platform by East Sussex Healthcare NHS Trust ("East Sussex" or the "Trust"). East...

CognivAiD provides a long-awaited option to fulfil the unmet needs of patients with vascular dementia. CognivAiD demonstrated significant and clinically meaningful disease-modifying benefits in clinical trials based on VaDAS-Cog and ADCS-CGIC...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces it will submit an updated briefing package to the U.S....

The Sabin Vaccine Institute today announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi-year contract with funding potential for up to $214 million to advance the development and production of...

TJP Labs Inc. ("TJP Labs") is proud to announce the acceptance of its Premarket Tobacco Product Application (PMTA) submission by the U.S. Food and Drug Administration for its brand, L!X modern oral nicotine pouches.  Marketed by its subsidiary L!X...

Field Trip Health & Wellness Ltd. ("Field Trip" or the "Company"), a global leader in the delivery of psychedelic therapies, today launched Field Trip Online Therapy, a unique approach to psychotherapy that leverages contemporary talk therapy,...